 |
 |

Measuring the Risk of Alzheimer Disease
Roger N. Rosenberg, MD, Editor
Arch Neurol. 2007;64(4):479-480.
 |
 |
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
 |
 |
All is created and goes according to order, yet o'er our lifetime rules an uncertain fate.—Johann Wolfgang von Goethe1
In recent years, there have been hundreds of published reports citing or refuting a genetic association of specific susceptibility genes and the occurrence of Alzheimer disease (AD).2-6 It is clear that mutations in the amyloid precursor protein (APP) gene (chromosome 21), presenilin 1 gene (chromosome 14), and presenilin 2 gene (chromosome 1) are causal of AD.7 It is also well established that the 4 allele of apolipoprotein E is a major susceptibility factor for AD.2, 4-5,7 However, a clear consensus of other potential susceptibility genes for AD remains to be reached. Progress in this regard has been achieved by Bertram et al,2 who have collected systematic analyses of AD genetic association studies in the AlzGene database, a publicly available, updated database that catalogs all genetic association . . . [Full Text of this Article] AUTHOR INFORMATION
RELATED ARTICLE
The Association Between Genetic Variants in SORL1 and Alzheimer Disease in an Urban, Multiethnic, Community-Based Cohort
, , , , , , , , , , and
Arch Neurol. ;64():501-506.
FULL TEXT
|